Quantcast

Latest Clinical trial Stories

2014-07-23 16:26:42

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Partial Seizure Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243634/Partial-Seizure-Global-Clinical-Trials-Review-H2-2014.htmlPartial Seizure Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Partial Seizure Global Clinical Trials Review, H2, 2014" provides data on the Partial Seizure clinical trial scenario. This report provides...

2014-07-23 16:26:38

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Neonatal Seizures Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243633/Neonatal-Seizures-Global-Clinical-Trials-Review-H2-2014.htmlNeonatal Seizures Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Neonatal Seizures Global Clinical Trials Review, H2, 2014" provides data on the Neonatal Seizures clinical trial scenario. This report...

2014-07-23 16:26:32

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243630/Intracerebral-Hemorrhage-Global-Clinical-Trials-Review-H2-2014.htmlIntracerebral Hemorrhage Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Intracerebral Hemorrhage Global Clinical Trials Review, H2, 2014" provides data on the Intracerebral Hemorrhage...

2014-07-23 12:32:49

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Hypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243628/Hypoxic-Ischemic-Encephalopathy-Global-Clinical-Trials-Review-H2-2014.htmlHypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Hypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H2, 2014" provides data on...

2014-07-23 12:32:42

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243627/Generalized-Tonic-Clonic-Seizure-Global-Clinical-Trials-Review-H2-2014.htmlGeneralized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014" provides data...

2014-07-23 12:32:31

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Generalized Seizures Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243626/Generalized-Seizures-Global-Clinical-Trials-Review-H2-2014.htmlGeneralized Seizures Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Generalized Seizures Global Clinical Trials Review, H2, 2014" provides data on the Generalized Seizures clinical trial...

2014-07-23 08:31:10

ENGLEWOOD, Colo., July 23 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced the opening of its new headquarters, manufacturing and research facility: Ampio Pharmaceuticals,373 Inverness ParkwayEnglewood, CO 80112Direct: (720) 437-6500 Michael Macaluso, Ampio's CEO, noted "This advanced, labor efficient, pharmaceutical drug manufacturing facility will be fully operational this summer, right on schedule, to produce the first batches of Ampion(TM)...

2014-07-22 12:25:40

Cortellis solution becomes Pharma's most comprehensive source for data on clinical trials in less than a year PHILADELPHIA, July 22, 2014 /PRNewswire/ -- The Intellectual Property and Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, today announced Cortellis Clinical Trials Intelligence, its global clinical-drug-trial intelligence database, marked an industry-first milestone with the documentation of more...

2014-07-22 08:32:36

Additional Independent Review Board Approvals Expected for Phase 2 Trial (Study 202) SAN DIEGO, July 22, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that it has resumed enrollment and dosing of patients in its ongoing Phase 2 trial (Study 202) evaluating PEGPH20 in patients with pancreatic cancer under the revised clinical protocol agreed to with the FDA in June. PEGPH20 is an investigational PEGylated form of Halozyme's proprietary recombinant...

2014-07-21 12:25:35

SAN ANTONIO, July 21, 2014 /PRNewswire-USNewswire/ -- ADB International Group Inc.: OTCQB: ADBI (ADBI or the Company) today announced a partnership with Austen BioInnovation Institute in Akron (ABIA or the Institute), for the purpose of bringing ADBI's E-QURE BST(TM), a bioelectrical signal therapy device (the E-QURE BST Device), to the U.S. market. The Institute, which has significant expertise in wound healing, clinical trial development and regulatory operations, will conduct a...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related